Physician profile
Kirk Nelson
NPI 1649242900
$4,948.99
in general payments reported to CMS, 2019-2025
38 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $958 · 2020: $382 · 2021: $817 · 2022: $1,097 · 2023: $814 · 2024: $498 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $848.04 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $710.55 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Actelion Pharmaceuticals US, INC. | $400.47 | 2019-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.34 | 2019-2025 | Ofev |
| United Therapeutics Corporation | $236.42 | 2019-2025 | Tyvaso, Orenitram, Remodulin |
| Insmed, INC. | $227.19 | 2019-2023 | Arikayce |
| Shionogi INC | $197.56 | 2021-2024 | Fetroja |
| Electromed, INC. | $180.51 | 2019-2025 | Smartvest |
| Inari Medical, INC. | $158.50 | 2019 | |
| Mylan Specialty L.P. | $131.79 | 2019-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $117.35 | 2021-2024 | Acthar |
| Regeneron Healthcare Solutions, INC. | $114.34 | 2021-2024 | Dupixent |
| Genzyme Corporation | $109.97 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.91 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.39 | 2020-2023 | Glassia |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $94.61 | 2022-2023 | |
| Philips North America LLC | $79.16 | 2019-2021 | |
| Gilead Sciences, INC. | $75.43 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $68.07 | 2022-2023 | Xarelto |
| Amgen INC. | $60.64 | 2021-2024 | Tezspire |
| Baxter Healthcare | $60.62 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $55.98 | 2024 | Winrevair |
| Csl Behring | $54.77 | 2019 | |
| Abbvie INC. | $53.50 | 2023 | |
| Abiomed | $51.27 | 2025 | |
| Ambu INC. | $39.79 | 2024-2025 | |
| Portola Pharmaceuticals, LLC | $38.30 | 2019 | |
| Inogen, INC. | $35.21 | 2022 | |
| Pulmonx Corporation | $31.39 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Shire North American Group INC | $22.93 | 2019 | |
| Ethicon INC. | $22.60 | 2022 | |
| Grifols USA, LLC | $22.19 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.02 | 2023 | Nuzyra |
| Vapotherm INC | $19.15 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.84 | 2019 | |
| Advanced Respiratory, INC | $18.77 | 2020 | |
| Tactile Systems Technology INC | $14.64 | 2025 | Nimbl, Flexitouch Plus |
| Nabriva Therapeutics, Plc | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.